Humphries Steve E, Gable David, Cooper Jackie A, Ireland Helen, Stephens Jeffrey W, Hurel Steven J, Li Ka Wah, Palmen Jutta, Miller Michelle A, Cappuccio Francesco P, Elkeles Robert, Godsland Ian, Miller George J, Talmud Philippa J
Department of Medicine, Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Royal Free and University College Medical School, London, WC1E 6JF, UK.
J Mol Med (Berl). 2006 Dec;84(12):1005-14. doi: 10.1007/s00109-006-0108-7.
Common variants of TCF7L2, encoding a beta-cell-expressed transcription factor, are strongly associated with increased risk of type 2 diabetes (T2D). We examined this association using both prospective and case-control designs. A total of 2,676 healthy European white middle-aged men from the prospective NPHSII (158 developed T2D over 15 years surveillance) were genotyped for two intronic SNPs [rs 7903146 (IVS3C>T) and rs12255372 (IVS4G>T)] which showed strong linkage disequilibrium (D' = 0.88, p<0.001; R(2)=0.76, p<0.001). The IVS5T allele frequency was 0.28 (95% CI 0.27-0.29) and 0.33 (0.28-0.39) in healthy and T2D, respectively (p=0.04). Compared to CC men, CT and TT men had an adjusted [for age, body mass index, systolic blood pressure, triglyceride and C-reactive protein levels] hazard ratio for T2D of 1.65 (1.13-2.41) and 1.87 (0.99-3.53), respectively, p<0.01. The population attributable fraction for diabetes risk was 17%. In 1459, European white T2D men and women (60% male), T allele frequency was 0.36 (0.34-0.38), and compared to NPHSII healthy men the OR for T2D for the CT and TT subjects was 1.43 (1.24-1.65) and 2.11 (1.69-2.63), respectively p=<0.0001. A similar effect was observed in 919 T2D Indian Asians [OR=1.50 (1.14-1.99) and 1.64 (1.03-2.63) p=0.003] and 385 Afro-Caribbean subjects [OR=1.25 (0.90-1.75) and 1.32 (0.74-2.33) p=0.17] compared to non-diabetic ethnically matched subjects from South London. Weaker associations were found for the IVS4G>T in all studies. Linkage disequilibrium between the two SNPs was high in Indian Asians (D'=0.94), but much weaker in Afro-Caribbeans (D'=0.17) and haplotype frequencies differed markedly in this group. These results extend previous observations to other ethnic groups, and strongly confirm that TCF7L2 genotype is a major risk factor for development of T2D.
编码一种在β细胞中表达的转录因子的TCF7L2常见变体与2型糖尿病(T2D)风险增加密切相关。我们采用前瞻性和病例对照设计来研究这种关联。对来自前瞻性NPHSII研究的2676名健康欧洲白人中年男性(在15年的随访中有158人患T2D)进行了两个内含子单核苷酸多态性[rs7903146(IVS3C>T)和rs12255372(IVS4G>T)]的基因分型,这两个位点显示出很强的连锁不平衡(D' = 0.88,p<0.001;R(2)=0.76,p<0.001)。在健康人群和T2D患者中,IVS5T等位基因频率分别为0.28(95%可信区间0.27 - 0.29)和0.33(0.28 - 0.39)(p = 0.04)。与CC基因型男性相比,CT和TT基因型男性患T2D的校正[校正年龄、体重指数、收缩压、甘油三酯和C反应蛋白水平]风险比分别为1.65(1.13 - 2.41)和1.87(0.99 - 3.53),p<0.01。糖尿病风险的人群归因分数为17%。在1459名欧洲白人T2D男性和女性(60%为男性)中,T等位基因频率为0.36(0.34 - 0.38),与NPHSII研究中的健康男性相比,CT和TT受试者患T2D的比值比分别为1.43(1.24 - 1.65)和2.11(1.69 - 2.63),p =<0.0001。在919名印度裔亚洲T2D患者[比值比=1.50(1.14 - 1.99)和1.64(1.03 - 2.63),p = 0.003]和385名非洲加勒比裔受试者[比值比=1.25(0.90 - 1.75)和1.32(0.74 - 2.33),p = 0.17]中观察到了类似的效应,与来自伦敦南部的非糖尿病种族匹配受试者相比。在所有研究中,IVS4G>T的关联较弱。在印度裔亚洲人中,这两个单核苷酸多态性之间的连锁不平衡较高(D' = 0.94),但在非洲加勒比裔中则弱得多(D' = 0.17),并且该组中的单倍型频率差异显著。这些结果将先前的观察结果扩展到了其他种族群体,并有力地证实了TCF7L2基因型是T2D发生的主要风险因素。